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Abstract 
In this paper Bayesian methods is performed on a medical trial Seizure count data set by introducing the new 
three parameter generalized Poisson model GPM(α,β,λ) as an alternative model to the standard Poisson model 
SPM(λ) which is considered on an earlier work for the generalized linear mixed model. The new model is 
developed by introducing two more parameters α and β called indicator parameters. The main advantage of an 
indicator parameter is that it gives the new Poisson model the mixture (when α>0,β=1,2) and non-mixture (when 
α=0) options. Another feature of proposed new model is that it generalize the posterior of the parameters to 
predict the behavior of the Seizure counts data, in agreement with generalized linear mixed model. Unlike 
earlier authors, who confined and limited their work only on standard Poisson model SPM(λ), to analyze the 
counts data in generalized linear mixed model, which make the new model more resilience and litheness. The 
parameters of the new model will be estimated using Bayesian approach that serves as a subtle tool for model 
selection and identification. An illustration is provided using the Seizure count data. The posterior summaries 
using Markov Chain Monte Carlo (MCMC) Gibbs sampling approach are presented for the new model for 
different values of the parameters. The study of the estimated parameters would help the users to have more 
prospect and clarity about the role of the new model. It is found that using proposed new model in generalized 
linear mixed model has more resiliency than standard Poisson model considered earlier. The proposed model is 
fully adaptive to the available data and gives scientists another option for modeling the data.  
Key words: Bayesian predictions; generalized Poisson model; generalized posterior; Gibbs sampling; Hierarchical  
model; Markov Chain Monte Carlo. 
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1. Introduction 
Multiple problems in applied statistical data counts research hinder the usage and application of standard 
Poisson model, and preferably circulate to a more generalized and extended setting of the Poisson model. This 
claim is well established in literature, see for example the work of  [3,4,5,6,7,8,9]. 
The main contribution of this paper is to introduce an efficient and more resilience computational Bayesian 
approach by introducing a new generalized statistical model with three parameters called generalized Poisson 
model GPM(α,β,λ) and compare it using clinical trial counts data analysis, with the standard Poisson model 
SPM(λ) implemented in [[2] model III]. The role of new parameters in the new generalized model as indicator 
parameters is to select, identify the more fit, more realistic, and genuine model for the data, and study the 
problem involving generalized linear mixed model of uncertain events in more extensive and comprehensive 
setting. In real life situation, problems involving new generalized and extended statistical model based 
prediction are well suited using the Bayesian methodology [see [10,11,12,13]]. The motivation of this work is to 
explore these new statistical models which can be implemented to provide an adequate fit for the real data than 
well-known available models. The Markov chain Monte Carlo (MCMC) Gibbs sampling methods are used to 
simulate direct draws from the new statistical models of interest. In section 2, we have proposed new 
generalized linear mixed model that considers the new generalized Poisson model GPM(α,β,λ) and introduce 
some of its properties. In section 3, we have developed the procedure to estimate the parameters of the 
generalized linear mixed model involving the new generalized Poisson model using Bayesian methodology. The 
Bayesian estimates of the parameters are obtained using Markov Chain Monte Carlo (MCMC) simulation 
technique based on the assumption that priors are independent, The generalized posterior analysis is performed 
and estimated. We have examined the issue of model compatibility with the work of [[2] model III] using new 
predictive results. A real medical trial Seizure count data set [see [1]] are analyzed for illustrating the 
application and the proposed Bayesian approach. 
2. The model 
In this section a new three parameter generalized Poisson model GPM(α,β,λ) is introduced with probability 
function 
(2.1)  fα,β,λ(x) =�
1
𝐶𝐶𝛼𝛼,β,𝜆𝜆� 𝜆𝜆𝑥𝑥 �1+𝛼𝛼𝑥𝑥1+𝛼𝛼𝛼𝛼�𝛽𝛽 𝑒𝑒−𝜆𝜆𝑥𝑥! ,  λ>0, α≥0, β=1,2, and x= 0,1,2,.., 
where 
𝐶𝐶𝛼𝛼,β,𝛼𝛼  = ∑ 𝜆𝜆𝑥𝑥 �1+𝛼𝛼𝑥𝑥1+𝛼𝛼𝛼𝛼�β 𝑒𝑒−𝜆𝜆𝑥𝑥!∞𝑥𝑥=0 . 
When α =0, the mean in (2.1) is E[x]=λ, and when α >0, β=1, we have 𝐶𝐶𝛼𝛼,1,𝛼𝛼=1, and the nean is 
(2.2)   E[x]= 𝛼𝛼𝛼𝛼
1+𝛼𝛼𝛼𝛼
+𝜆𝜆 
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The mean when α >0, β=2, is 
(2.3)   E[x]= (𝛼𝛼(1+2𝛼𝛼)+2)𝛼𝛼𝛼𝛼
1+𝛼𝛼(1+𝛼𝛼)𝛼𝛼2+2𝛼𝛼𝛼𝛼+𝜆𝜆. 
In some particular cases the parameters α, and β of model (2.1) can be seen as providing not only an extra 
flexibility to the probability function, but also helps to express probability distribution as an exact form of 
mixture of probability distributions under certain conditions. We should emphasize that eqn (2.1) can be reduced 
to standard Poisson model (f0,β,λ(x)=Poisson(λ)). 
The generalized linear mixed model (model III) considered by [2] is generalized by using the new probability 
function (2.1) when α≥ 0, and β =1, 2. For distinctness, the model is explained through the data from [1] 
concerning seizure counts in a randomized medical trial of anti-conversant therapy in epilepsy. For ready 
reference, the data is reproduced in Table A (see Appendix) which shows the seizure counts for 59 hospitalized 
patients. The covariates are treatment (0=Placebo, 1=Progabide drug), 8-week baseline seizure counts, and age 
in years. While considering the model, we used the same transformation which [2] considered in their (model 
III). For example, “Base” in the data set is transformed to log(Base/4), Age to log(Age), and the treatment times 
log(Base/4) where their interaction is included. To test the new model (2.1), we also considered the random 
effects for both individual subjects SS1j and also subject by visit random effects SSjk variability within subjects. 
V4 is an indicator variable for the 4th visit. The model considered below leads to a Markov chain that is highly 
correlated with poor convergence properties. In order to overcome this poor convergence property, each 
covariate is standardized about its mean to ensure approximate prior independence between the regression 
coefficients as shown below: 
(i) SPMM : Standard Poisson Mixed Model [see [2] model III] 
(1) y
jk
  ~  �𝜆𝜆𝑗𝑗𝑗𝑗�
𝑥𝑥𝑗𝑗𝑗𝑗 𝑒𝑒
−𝜆𝜆𝑗𝑗𝑗𝑗
𝑥𝑥𝑗𝑗𝑗𝑗! ,   
(2) log(𝜆𝜆𝑗𝑗𝑗𝑗 )= C0 + CBase log�
𝐵𝐵𝐵𝐵𝐵𝐵𝑒𝑒𝑗𝑗
4
� + C
Trt 
 Trt
j
 + C
BT
Trt
j log�
𝐵𝐵𝐵𝐵𝐵𝐵𝑒𝑒𝑗𝑗
4
�+ C
Age Agej +CV4V4+S S1j + SSjk 
(3) SS1j  ~ Normal(0, tb1)  
(4) SSjk ~ Normal(0, tb) 
(ii) GPMM 1: Generalized Poisson Mixed Model 1 
(1) y
jk
  ~  �𝜆𝜆𝑗𝑗𝑗𝑗�
𝑥𝑥𝑗𝑗𝑗𝑗 �
1+𝛼𝛼𝑗𝑗𝑗𝑗𝑥𝑥𝑗𝑗𝑗𝑗
1+𝛼𝛼𝑗𝑗𝑗𝑗𝑥𝑥𝑗𝑗𝑗𝑗
�
𝑒𝑒
−𝜆𝜆𝑗𝑗𝑗𝑗
𝑥𝑥𝑗𝑗𝑗𝑗! , 
(2) log(
𝛼𝛼𝑗𝑗𝑗𝑗𝛼𝛼𝑗𝑗𝑗𝑗
1+𝛼𝛼𝑗𝑗𝑗𝑗𝛼𝛼𝑗𝑗𝑗𝑗
+𝜆𝜆𝑗𝑗𝑗𝑗 )=C0 + CBase log�
𝐵𝐵𝐵𝐵𝐵𝐵𝑒𝑒𝑗𝑗
4
�+ C
Trt 
 Trt
j
 +C
BT
Trt
j log�
𝐵𝐵𝐵𝐵𝐵𝐵𝑒𝑒𝑗𝑗
4
�+C
Age Agej +CV4V4+SS1j + SSjk 
(3) SS1j  ~ Normal(0, TS1)  
(4) SSjk ~ Normal(0,TS) 
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(iii) GPMM 2: Generalized Poisson Mixed Model 2  
(1) y
jk
  ~  �𝜆𝜆𝑗𝑗𝑗𝑗�
𝑥𝑥𝑗𝑗𝑗𝑗 �
1+𝛼𝛼𝑗𝑗𝑗𝑗𝑥𝑥𝑗𝑗𝑗𝑗
1+𝛼𝛼𝑗𝑗𝑗𝑗𝛼𝛼𝑗𝑗𝑗𝑗
�
2
𝑒𝑒
−𝜆𝜆𝑗𝑗𝑗𝑗
𝑥𝑥𝑗𝑗𝑗𝑗! ,   
(2) log��
(𝛼𝛼𝑗𝑗𝑗𝑗�1+2𝛼𝛼𝑗𝑗𝑗𝑗�+2)𝛼𝛼𝑗𝑗𝑗𝑗𝛼𝛼𝑗𝑗𝑗𝑗
1+𝛼𝛼𝑗𝑗𝑗𝑗�1+𝛼𝛼𝑗𝑗𝑗𝑗�𝛼𝛼𝑗𝑗𝑗𝑗2+2𝛼𝛼𝑗𝑗𝑗𝑗𝛼𝛼𝑗𝑗𝑗𝑗
� + 𝜆𝜆𝑗𝑗𝑗𝑗� 
         = C
0
 + C
Base log�
𝐵𝐵𝐵𝐵𝐵𝐵𝑒𝑒𝑗𝑗
4
� + C
Trt 
 Trt
j
 + C
BT
Trt
j log�
𝐵𝐵𝐵𝐵𝐵𝐵𝑒𝑒𝑗𝑗
4
�+ C
Age Agej +CV4V4+SS1j +SSjk 
(3) SS1j  ~ Normal(0, TS1)  
(4) SSjk ~ Normal(0, TS) 
We should emphasis that all coefficients and precisions of model (i)-(iii) are given independent "non-
informative'' priors.   
3. Bayesian updating prediction data analysis 
A realistic Bayesian model for the Seizure count data is to suggest the following hierarchical model:  
(a) At the first stage we assume that the count data follow the SPM, GPM 1, and GPM 2, respectively.  
(b) At the second stage we assume the following prior specification for the parameter α~exponential(0.1), 
and also we assume the following prior specifications  
C0 ~ Normal(0.0,1.0E-5)               
  CBase ~ Normal(0.0,1.0E-5)             
  CTrt ~ Normal(0.0,1.0E-5);            
  CBT ~ Normal(0.0,1.0E-5)             
  CAge ~ Normal(0.0,1.0E-5)             
  CV4 ~Normal(0.0,1.0E-5) 
  SS1 ~ Gamma(1.0E-4,1.0E-4); where SS1 = 1
√𝑇𝑇𝑇𝑇1
 
  SS ~ Gamma(1.0E-4,1.0E-4); where SS =  1
√𝑇𝑇𝑇𝑇
        
A Markov Chain Monte Carlo (MCMC) Gibbs sampling approach implemented in using OPENBUGS@ 
computer software can give an analysis of estimates of each parameter.  
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A burn in of 1000 updates followed by a further 20k updates is implemented. The table 3.1, represent the 
coefficient estimates for SPMM, the table 3.2, represent the coefficient estimates for GPMM 1, where the table 
3.3, represent the coefficient estimates for GPMM 2, along with standard deviation, mean and MC error.  
 
 Table 3.1: Bayesian summary 
for α=0, Model SPMM 
Table 3.2: Bayesian summary for 
α>0, β=1, Model GPMM 1 Table 3.3: Bayesian summary forα>0, β=2, Model GPMM 2 
 Mean SD MC error Mean SD MC error Mean SD MC error 
CAge 0.4657 0.3684 0.01396 0.2941 0.484 0.04712 -0.6236 0.1239 0.01227 
CBT 0.3385 0.2151 0.01208 0.1293 0.1821 0.01776 -0.1736 0.1839 0.01876 
CBase 0.8786 0.1462 0.008372 0.9292 0.2052 0.01994 1.198 0.1542 0.01504 
CTrt -0.9357 0.4251 0.02097 -0.6574 0.3822 0.03727 -0.1222 0.3136 0.03208 
CV4 -0.1022 0.0869 0.001852 -0.1292 0.09721 0.008823 -0.1712 0.09761 0.009652 
C0 -1.332 1.248 0.04975 0.4442 1.765 0.1721 2.862 0.3045 0.03032 
SS 0.3647 0.0561 0.002633 0.35 0.05668 0.004067 0.447 0.07737 0.006636 
SS1 0.4989 0.0730 0.002762 0.5969 0.1159 0.008981 0.6556 0.08867 0.004404 
 
 
Figure 1: Comparisons of Seizure count data estimates between models SPMM, GPMM 1, and GPMM 2 
 
  
 
CAge CBT CBase CTrt CV4 C0 SS SS1
SPMM 0.4657 0.3385 0.8786 -0.9357 -0.1022 -1.332 0.3647 0.4989
GPMM 1 0.2941 0.1293 0.9292 -0.6574 -0.1292 0.4442 0.35 0.5969
GPMM 2 -0.6236 -0.1736 1.198 -0.1222 -0.1712 2.862 0.447 0.6556
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Table 3.4:  Bayesian summary estimates for α, whe    αjk≥ 0, β=1 Model GPMM 1 
j 𝛂𝛂�j1 𝛂𝛂�j2 𝛂𝛂�j3 𝛂𝛂�j4 
1 0.8823 1.08 1.132 1.062 
2 1.087 0.8857 1.078 1.066 
3 1.082 0.8871 0.9573 0.7573 
4 0.9502 0.9375 1.199 0.9295 
5 1.499 0.7103 1.275 0.5273 
6 1.104 1.373 0.8225 0.8517 
7 0.7375 0.9802 0.9626 1.148 
8 0.4216 1.021 0.9892 1.376 
9 1.093 1.014 0.9765 1.045 
10 0.4931 0.5497 1.039 1.087 
11 0.543 1.223 1.688 0.5752 
12 0.6814 1.177 0.9981 1.257 
13 1.086 1.052 0.8331 1.233 
14 1.34 1.118 0.9119 0.6844 
15 0.9234 0.5582 1.339 1.297 
16 0.5096 1.069 1.063 0.9632 
17 0.943 0.9274 1.007 1.004 
18 0.811 1.033 1.041 0.8966 
19 1.171 0.9419 1.26 0.9103 
20 1.16 1.037 0.8249 0.6609 
21 1.1 1.016 1.105 0.9467 
22 1.086 0.9936 1.086 0.9526 
23 1.2 1.137 1.105 0.8738 
24 0.926 0.6431 1.481 0.8669 
25 1.54 1.19 0.28 1.05 
26 1.07 1.135 1.079 1.09 
27 1.032 1.159 0.9099 1.094 
28 0.9833 0.8421 1.013 0.9546 
29 0.9596 0.759 1.094 1.127 
30 0.9239 1.031 0.8298 1.214 
31 0.9021 0.89 0.9791 0.9116 
32 1.04 0.7122 1.145 1.007 
33 1.243 0.8326 0.7402 1.042 
34 0.962 1.084 1.231 1.046 
35 0.6823 0.9127 0.8105 0.8421 
36 0.9982 1.047 0.7897 1.036 
37 1.099 0.8714 0.954 0.876 
38 1.407 1.019 1.018 0.9441 
39 1.286 0.3608 1.471 1.111 
40 1.034 1.074 1.108 0.895 
41 0.9065 1.059 0.8691 0.9005 
42 0.8442 0.93 0.9706 1.025 
43 1.293 1.062 0.555 0.8473 
44 0.7172 1.129 1.345 0.7959 
45 0.4504 1.157 1.273 1.121 
46 1.13 1.102 1.04 0.9358 
47 1.141 0.8311 0.9854 0.9184 
48 1.087 1.099 0.9017 0.8808 
49 0.5053 1.041 0.874 0.9479 
50 0.9708 1.093 1.211 0.9566 
51 0.8744 1.04 1.193 0.9136 
52 1.213 1.073 1.224 0.8332 
53 0.8828 1.294 0.5057 1.063 
54 0.7711 1.117 0.9973 0.983 
55 1.086 0.8802 0.9749 1.059 
56 1.644 0.3578 0.4772 1.012 
57 1.092 0.9596 0.9162 1.123 
58 0.9181 0.909 0.9127 0.904 
59 1.142 0.9079 1.001 1.093 
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Table 3.5:  Bayesian summary estimates for α, whe  αjk≥ 0, β=2 Model GPMM 2 
j 𝛂𝛂�j1 𝛂𝛂�j2 𝛂𝛂�j3 𝛂𝛂�j4 
1 1.031 1.202 1.215 1.21 
2 1.209 1.018 1.259 1.208 
3 1.278 1.123 0.6939 0.9935 
4 1.089 1.113 1.207 1.115 
5 1.408 0.8496 1.343 0.6483 
6 1.17 1.342 0.9277 0.9533 
7 0.8745 1.137 0.6919 1.305 
8 0.5043 0.9518 0.9845 1.236 
9 1.148 1.086 1.068 1.128 
10 0.5782 0.6268 1.102 0.6778 
11 0.6367 1.15 1.546 0.629 
12 0.7762 1.188 1.057 1.307 
13 1.184 1.177 0.9624 1.283 
14 1.263 1.122 0.943 0.7398 
15 0.9914 0.7048 1.344 1.288 
16 0.6389 0.6469 0.6708 1.05 
17 0.6931 0.7021 1.235 1.243 
18 0.833 1.097 1.025 0.9002 
19 1.175 1.065 1.286 1.059 
20 1.259 0.6647 1.005 0.8706 
21 1.214 1.135 1.209 1.155 
22 1.26 1.162 1.247 1.139 
23 1.285 1.243 1.227 1.041 
24 1.018 0.7938 1.435 0.9764 
25 1.4 1.175 0.3752 0.9974 
26 1.359 1.246 1.312 1.294 
27 1.21 1.199 1.106 1.312 
28 1.039 0.9325 1.072 0.9867 
29 1.048 0.8666 1.191 1.173 
30 0.9511 1.057 0.911 1.251 
31 0.6809 1.141 1.268 0.6667 
32 1.224 0.922 1.183 1.173 
33 1.29 1.024 0.9364 1.175 
34 1.156 1.217 1.224 1.188 
35 0.7561 0.9618 0.8775 0.8733 
36 1.093 1.197 0.917 1.162 
37 1.276 1.16 0.6969 1.103 
38 1.388 1.091 1.074 1.017 
39 1.271 0.4717 1.384 1.188 
40 1.365 1.341 1.358 0.7597 
41 0.7086 1.28 1.131 0.712 
42 1.011 1.15 0.6643 1.22 
43 1.197 1.012 0.6524 0.8668 
44 0.8456 1.231 1.332 0.9322 
45 0.5273 1.148 1.232 1.086 
46 1.258 1.281 1.317 1.259 
47 1.224 0.9063 1.045 0.9752 
48 1.354 1.342 0.7529 0.7762 
49 0.7273 0.8665 0.7551 0.8251 
50 1.143 1.273 1.317 1.124 
51 1.002 1.141 1.199 1.022 
52 1.199 1.232 1.186 1.05 
53 0.9191 1.234 0.5913 1.006 
54 0.9328 1.222 1.147 0.6903 
55 1.246 1.038 1.155 1.244 
56 1.336 0.4808 0.5539 1.086 
57 1.275 1.257 0.6867 1.259 
58 0.7632 0.7869 0.8097 0.8158 
59 1.215 1.083 1.198 1.303 
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We should emphasizes that the estimates in (Tables 3.1-3.5 and Figure 1) give more information about the 
behavior of seizure counts data than that of [2] who considered SPMM only in their work. This can be easily 
seen, by comparing the above results  with their reported estimates, and they are: CAge= 0.47 +/- 0.35, CBT= 
0.34 +/- 0.21, CBase = 0.86 +/- 0.13, CTrT= -0.93 +/- 0.40, CV4= -0.10 +/- 0.90, C0 = -1.27 +/- 1.2, SS1 = 0.48 
+/- 0.06, and SS = 0.36+/-0.04.  
Examination of the above simulations yields the following observations:  
1. The posterior mean of the estimate CAge of models SPMM, GPMM 1, and GPMM 2 are 0.4657, 0.2941, 
and -0.6236, respectively. There is a clear and substantial shift of the posterior mean to the left. The 
posterior standard deviation (SD) is 0.3684, 0.484 and 0.1239, respectively, and hence a decrease in 
posterior SD. Comparison of the MC error for SPMM, GPMM 1 and GPMM 2 shows that the MC 
error are about the same. 
2. The posterior mean of the estimate CBt of models SPMM, GPMM 1, and GPMM 2 are 0.3385, 0.1293, 
and -0.1736 respectively. There is a clear and substantial shift of the posterior mean to the left. The 
posterior standard deviation (SD) is 0.1462, 0.1821 and 0.1839, respectively, and hence about the same 
result in posterior SD. Comparison of the MC error for SPMM, GPMM 1 and GPMM 2 shows also, 
that the MC error are about the same. 
3. The posterior mean of the estimate CBase of models SPMM, GPMM 1, and GPMM 2 are 0.8786, 0.9292 
and 1.198, respectively. There is a slight shift of the posterior mean to the right. Comparison of the 
posterior standard deviation (SD) and the MC error for SPMM, GPMM 1 and GPMM 2 shows that 
they are about the same. 
4. The posterior mean of the estimate CTrt of models SPMM, GPMM 1, and GPMM 2 are -0.9357, -0.6574 
and -0.1222, respectively. There is a clear and substantial shift of the posterior mean to the right. The 
posterior standard deviation (SD) is 1.248, 1.765 and 0.3045, respectively, and hence a decrease in 
posterior SD. Comparison of the posterior standard deviation (SD) and the MC error for SPMM, 
GPMM 1 and GPMM 2 shows that they are about the same. 
5. The posterior mean of the estimate CV4 of models SPMM, GPMM 1, and GPMM 2 are -0.1022, -0.1292 
and -0.1712, respectively. There is a slight shift of the posterior mean to the lift. The posterior standard 
deviation (SD) is 1.248, 1.765 and 0.3045, respectively, and hence a decrease in posterior SD. 
Comparison of the posterior standard deviation (SD) and the MC error for SPMM, GPMM 1 and 
GPMM 2 shows that they are about the same. 
6. The posterior mean of the estimate C0 of models SPMM, GPMM I, and GPMM 2 are -1.332, 0.4442 and 
2.862, respectively. There is a clear and substantial shift of the posterior mean to the right. The 
posterior standard deviation (SD) is 1.248, 1.765 and 0.3045, respectively, and hence a decrease in 
posterior SD. Comparison of the MC error for SPMM, GPMM I and GPMM 2 shows that the MC error 
are about the same.  
7. The posterior mean of the estimate SS of models SPMM, GPMM I, and GPMM 2 are 0.3647, 0.35 and 
0.447, respectively. There is a slight shift of the posterior mean to the right. Comparison of the 
posterior standard deviation (SD) and MC error for SPMM, GPMM I and GPMM 2 shows that the MC 
error are about the same.  
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8. The posterior mean of the estimate SS1 of models SPMM, GPMM I, and GPMM 2 are -1.332, 0.4442 
and 2.862, respectively. There is a clear and substantial shift of the posterior mean to the right. The 
posterior standard deviation (SD) is 1.248, 1.765 and 0.3045, respectively, and hence a decrease in 
posterior SD. Comparison of the MC error for SPMM, GPMM I and GPMM 2 shows that the MC error 
are about the same. 
9. The posterior mean of the estimate α of models GPMM 1 (table 3.4) vary between (0.4216, 1.54) in the 
first two weeks of treatments, for second two weeks of treatments it vary between (0.3608, 1.373), for 
third two weeks of treatments it vary between (0.28, 1.47), and for fourth two weeks of treatments it 
vary between (0.5273, 1.376). This indicate that the seizure counts data are mixing in the generalized 
linear mixed model GPMM 1. These findings do not sport the work done by [2] using SPM(λ). We 
also note the following embodiment: (i) patient (No. 8) is an interesting subject, where for the first two 
weeks of treatments, he/she has the lowest estimated value α at 0.4216 (with high number of seizure 
counts at 40 counts), at the second two weeks of treatments, the estimate increased to 1.021 (number of 
seizure counts decreased to 20 counts), at the third two weeks of treatments, he/she has the estimate at 
0.8982 (number of seizure counts increased by one count to 21 counts), and at the fourth two weeks of 
treatments, he/she has the estimate at 1.376 which is the highest estimate in the fourth two week 
treatments group (with a drop in the number of seizure counts to 12 counts). This maybe, related to the 
factor effect of either baseline data on the number of epileptic seizures which is the next highest at 52 
counts, and/or to his/her age at 42 years old (which is the highest in the age group). (ii) patient (No. 25) 
where for the first two weeks of treatments, he/she has the highest estimated value α at 1.54 (with 
number of seizure counts at 18 counts), at the second two weeks of treatments, the estimate is 1.19 
(number of seizure counts increased to 24 counts), at the third two weeks of treatments, he/she has the 
lowest estimate of the group at 0.28 (number of seizure counts jumped at 76 counts), and at the fourth 
two weeks of treatments, he/she has the estimate at 1.05 (with a drop in the number of seizure counts to 
25 counts). This may be, related to the factor effect of either baseline data on the number of epileptic 
seizures which is high at 55 counts, and/or to his/her age at 30 years old . (iii) patient (No. 39) where 
for the first two weeks of treatments, he/she has the estimated value α at 1.286 (with low number of 
seizure counts at 4 counts), at the second two weeks of treatments, he/she has the lowest estimate at 
0.368 (number of seizure counts increased to 18 counts), at the third two weeks of treatments, he/she 
has the highest estimate of the group at 1.471 (number of seizure counts dropped to 2 counts), and at 
the fourth two weeks of treatments, he/she has the estimate at 1.111 (with a slight increase in the 
number of seizure counts to 5 counts). This maybe, related to the factor effect of either baseline data on 
the number of epileptic seizures which is at 41 counts, and/or to the type of drug treatment (Progabide 
drug), and/or to his/her age at 22 years old. 
10. The posterior mean of the estimate α of models GPMM 2 (table 3.5) vary between (0.5043,1.408) in 
the first two weeks of treatments, for second two weeks of treatments it vary between (00.4717,1.341), 
for third two weeks of treatments it vary between (0.5539,1.546), and for fourth two weeks of 
treatments it vary between (0.629,1.312). Which as indicated earlier for GPMM 1 the seizure counts 
data are mixing in the generalized linear mixed model GPMM 2 and hence, they do not sport the work 
done by [2] Breslow and Clayton (1993) using SPM(λ). We also note the following embodiment: (i) 
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patient (No. 5), for the first two weeks of treatments, he/she has the highest estimated value α at 1.408 
(with low number of seizure counts at 7 counts), at the second two weeks of treatments, the estimate 
deccreased to 0.8496 (number of seizure counts increased to 18 counts), at the third two weeks of 
treatments, he/she has the estimate at 1.343 (number of seizure counts decreased 9 counts), and at the 
fourth two weeks of treatments, he/she has the estimate at 0.6843 (with a jump in the number of seizure 
counts to 21 counts). This maybe, related to the factor effect of either baseline data on the number of 
epileptic seizures which is the next high at 66 counts, and/or to his/her age at 22 years old. (ii) patient 
(No. 11) where for the first two weeks of treatments, he/she has the estimated value α at 0.6367 (with 
number of seizure counts at 26 counts), at the second two weeks of treatments, the estimate is 1.15 
(number of seizure counts decreased to 12 counts), at the third two weeks of treatments, he/she has the 
highest estimate of the group at 1.516 (number of seizure counts down to 6 counts), and at the fourth 
two weeks of treatments, he/she has the estimate at 0.629 which is lowest in the group (with an 
increase in the number of seizure counts to 22 counts). This maybe, related to the factor effect of either 
baseline data on the number of epileptic seizures which is high at 52 counts, and/or to his/her age at 36 
years old. (iii) patient (No. 39) where for the first two weeks of treatments, he/she has the estimated 
value α at 1.271 (with low number of seizure counts at 4 counts), at the second two weeks of 
treatments, he/she has the lowest estimate at 0.4717 (number of seizure counts increased to 18 counts), 
at the third two weeks of treatments, he/she has the estimate at 1.384 (number of seizure counts 
dropped to 2 counts), and at the fourth two weeks of treatments, he/she has the estimate at 1.188 (with 
a slight increase in the number of seizure counts to 5 counts). This maybe, related to the factor effect of 
either baseline data on the number of epileptic seizures which is at 41 counts, and/or to the type of drug 
treatment (Progabide), and/or to his/her age at 22 years old. (vi) patient (No. 40) where for the first two 
weeks of treatments, he/she has the estimated value α at 1.365 (with low number of seizure counts at 2 
counts), at the second two weeks of treatments, he/she has the highest estimate of the group at 1.341 
(number of seizure counts decreased to 1 counts), at the third two weeks of treatments, he/she has the 
estimate at 1.358 (number of seizure counts stayed at 1 counts), and at the fourth two weeks of 
treatments, he/she has the estimate at 0.7597 (with a slight decrease in the number of seizure counts to 
0 counts). This maybe, related to either baseline data on the number of epileptic seizures which is at 
low 7 counts, and/or to the type of treatment (Progabide), and/or to his/her age at 28 years old. (v) 
patient (No. 56) for the first two weeks of treatments, he/she has the estimated value α at 1.336 (with 
low number of seizure counts at 1 counts), at the second two weeks of treatments, he/she has the 
estimate at 0.4808 (number of seizure counts increased to 23 counts), at the third two weeks of 
treatments, he/she has the lowest estimate of the group at 0.5539 (number of seizure counts dropped to 
19 counts), and at the fourth two weeks of treatments, he/she has the estimate at 1.086 (with a decrease 
in the number of seizure counts to 8 counts). This maybe, related to the factor effect of either baseline 
data on the number of epileptic seizures which is at 22 counts, and/or to the type of drug treatment 
(Progabide), and/or to his/her age at 26 years old. 
In brief, the values of the posterior means of estimates vary to some extent across the results for models SPMM, 
GPMM 1, and GPMM 2. For a few estimators, the values are similar. However, the differences for CAge, CBt, 
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CTrt and C0 are dramatic. The difference is clearer in the case when α>0 (mixture model) compared to α=0 
(non-mixture model). Hence we think, in the above illustration, the analysis using the new generalized Poisson 
model for the Seizure count data seems more successful than the standard Poisson model (α=0) considered by 
[2]. The proposed class of new generalized distributions offers more flexibility for Bayesian methods to choose 
among the existing classes of distribution models. 
4. Conclusion 
In this paper we investigated the impact of having a new three parameter generalized Poisson probability model 
GPM(α,β,λ) as an alternative model to the standard Poisson model SPM(λ) in (model III) of [2] generalized 
linear mixed model. We have shown the importance and usefulness of the new GPMM through the Seizure 
count data set, which are available and used by authors in the past. Another feature of proposed new generalized 
linear mixed model, is that under Bayesian perspective, it generalize the posterior of the parameters to predict 
the behavior of the Seizure count data which make the new model more resilience and litheness. Unlike the 
work of [[2] model III] who confined and limited there work only on standard Poisson model SPM(λ) to analyze 
the count data in generalized linear mixed model. The present study helps to identify problems involving 
uncertain events, and gives an efficient computational Bayesian approach with new ways of predicting and 
measuring behavior. 
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5. Appendix 
5.1.  Description of the data set 
The data set in table A taken from [1], represent a placebo-controlled medical randomized clinical trial to 59 
epileptics. Patients who are diagnosed with partial seizures were enrolled in a randomized medical trial of the 
anti-epileptic drug, called progabide. The participants in the study were randomized to either take progabide or a 
placebo, as an adjuvant to the standard anti-epileptic chemotherapy. The drug progabide has an anti-epileptic 
function which binds to both GABAA and GABAB receptors and is located on the terminals of primary afferent 
fibers and is the primary inhibitory neurotransmitter in the brain. Activation of the GABAB receptors retards the 
influx of calcium ions into the terminals, thereby reducing the evoked release of excitatory amino acids and 
possibly other transmitters. Prior to receiving treatment, baseline data on the number of epileptic seizures during 
the preceding eight week interval were recorded. Counts of epileptic seizures during two week intervals before 
each of four successive post-randomization clinic visits were recorded. Patient ID, Treatment (0=Placebo, 
1=Progabide drug), Age, Baseline 8 week seizure count, First two week seizure count, Second two week seizure 
count, Third two week seizure count, Fourth two week seizure count. A total of five seizure counts were 
recorded.  
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Table A 
 
j yj1 yj2 yj3 yj4 Trtj Basej Agej 
1 5 3 3 3 0 11 31 
2 3 5 3 3 0 11 30 
3 2 4 0 5 0 6 25 
4 4 4 1 4 0 8 36 
5 7 18 9 21 0 66 22 
6 5 2 8 7 0 27 29 
7 6 4 0 2 0 12 31 
8 40 20 21 12 0 52 42 
9 5 6 6 5 0 23 37 
10 14 13 6 0 0 10 28 
11 26 12 6 22 0 52 36 
12 12 6 8 4 0 33 24 
13 4 4 6 2 0 18 23 
14 7 9 12 14 0 42 36 
15 16 24 10 9 0 87 26 
16 11 0 0 5 0 50 26 
17 0 0 3 3 0 18 28 
18 37 29 28 29 0 111 31 
19 3 5 2 5 0 18 32 
20 3 0 6 7 0 20 21 
21 3 4 3 4 0 12 29 
22 3 4 3 4 0 9 21 
23 2 3 3 5 0 17 32 
24 8 12 2 8 0 28 25 
25 18 24 76 25 0 55 30 
26 2 1 2 1 0 9 40 
27 3 1 4 2 0 10 19 
28 13 15 13 12 0 47 22 
29 11 14 9 8 1 76 18 
30 8 7 9 4 1 38 32 
31 0 4 3 0 1 19 20 
32 3 6 1 3 1 10 30 
33 2 6 7 4 1 19 18 
34 4 3 1 3 1 24 24 
35 22 17 19 16 1 31 30 
36 5 4 7 4 1 14 35 
37 2 4 0 4 1 11 27 
38 3 7 7 7 1 67 20 
39 4 18 2 5 1 41 22 
40 2 1 1 0 1 7 28 
41 0 2 4 0 1 22 23 
42 5 4 0 3 1 13 40 
43 11 14 25 15 1 46 33 
44 10 5 3 8 1 36 21 
45 19 7 6 7 1 38 35 
46 1 1 2 3 1 7 25 
47 6 10 8 8 1 36 26 
48 2 1 0 0 1 11 25 
49 102 65 72 63 1 151 22 
50 4 3 2 4 1 22 32 
51 8 6 5 7 1 41 25 
52 1 3 1 5 1 32 35 
53 18 11 28 13 1 56 21 
54 6 3 4 0 1 24 41 
55 3 5 4 3 1 16 32 
56 1 23 19 8 1 22 26 
57 2 3 0 1 1 25 21 
58 0 0 0 0 1 13 36 
59 1 4 3 2 1 12 37 
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